Literature DB >> 14561800

Lessons learned from the management of a rare genetic cancer.

Gilbert J Cote, Robert F Gagel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14561800     DOI： 10.1056/NEJMe038148

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Routine screening for germline RET mutations is recommended for all patients with medullary thyroid cancer.

Authors:  Diana L Learoyd; Bruce G Robinson
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-11-11

Review 2.  Multiple endocrine neoplasia type 2.

Authors:  Mariola Peczkowska; Andrzej Januszewicz
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 3.  Thyroid Cancer: Role of RET and Beyond.

Authors:  Francesca Carlomagno
Journal:  Eur Thyroid J       Date:  2012-03-28

4.  Sequence variant in the intron 10 of the RET oncogene in a patient with microfollicular thyroid carcinoma with medullar differentiation: implications for newly generated chi-like sequence.

Authors:  Emilija Veljkovic; Radan Dzodic; Gorana Neskovic; Boban Stanojevic; Zorka Milovanovic; Miroslav Opric; Bogomir Dimitrijevic
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

5.  Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers.

Authors:  Taccaliti A; Silvetti F; Palmonella G; Boscaro M
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.